Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Risks listed by the department The advisory enumerates specific risks associated with unauthorized or counterfeit products, including: containing too much, too little, or none of the active ingredient containing unlisted, dangerous or unknown ingredients containing contaminants such as solvents, heavy metals, particles, or microbials being poorly or incorrectly labelled, or improperly manufactured or stored Health Canada adds that unauthorized injectable products carry additional risks such as infections due to lack of sterility, allergic reactions, and other serious negative outcomes due to contamination, improper handling, or unsafe administration
6?5, 8
As patents for several GLP-1 drugs approach expiration, many pharmaceutical companies are developing biosimilar or follow-on versions
Feng, P., Yu, D
PMCID: PMC5472315
)
